Code of Business Conduct and Ethics

Cardiva Medical, Inc.’s management and employees are dedicated to high ethical standards and recognize the Company’s duty to conduct its affairs within the bounds of the law. The Company has formalized certain business policies and practices in this Code of Business Conduct and Ethics. The Code of Conduct is designed to ensure that the Company and its employees and agents are in compliance with all applicable laws and regulations concerning good engineering, clinical, manufacturing, laboratory, regulatory, labeling, sales and marketing activities, third-party reimbursement of the cost of its products, human resources and environmental practices.

Cardiva Company Milestones

VASCADE MVP® receives FDA approval for 6-12F Inner Diameter (ID) multi-vessel venous vascular closure

Antegrade Study results published in Vascular Disease Management in 2018

VASCADE® receives FDA approval for use in femoral veins in 2018

VASCADE VCS approved by the FDA in 2013

VASCADE VCS approved for CE Mark in Europe in 2012

CATALYST III received 510(k) clearance in 2009

CATALYST II approved for CE Mark in Europe in 2008

CATALYST II received 510(k) clearance in 2007